Human CKMB enzyme-linked immunoassay kit

CAT: EH0072 Datasheet
Specification 96 Test
Sensitivity 0.005 pg/ml (50 μl);0.07 ng/ml (10 μl)
Standard Curve Range 0.04~30 ng/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 2
Sample Volume 50 μl/10 μl
Type Ready-to-Use
Operation Duration 120min
ng/ml O.D. Average Corrected
0.00 0.0144 0.0158 0.0151
0.04 0.0332 0.0309 0.0321 0.0170
0.12 0.0716 0.0726 0.0721 0.0570
0.37 0.1778 0.1780 0.1779 0.1628
1.11 0.4794 0.4464 0.4629 0.4478
3.33 1.3260 1.3850 1.3555 1.3404
10.00 3.2180 3.2230 3.2205 3.2054
30.00 4.5063 4.4600 4.4832 4.4681

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(ng/ml) 0.7 3.8 13.1 0.6 3.2 11.0
Standard Deviation 0.1 0.2 1.0 0.1 0.1 0.3
Coefficient of Variation(%) 5.6 4.6 7.3 3.6 3.9 3.1

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of human CKMB into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 79% to 119% with an overall mean recovery of 103%.

Sample Values

Sample Matrix Sample Evaluated Range (ng/ml) Detectable (%) Mean of Detectable (ng/ml)
Serum 30 n.d.-0.06 40 0.02

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of CKMB in this assay. No medical histories were available for the donors.

Background: CKMB

The creatine kinase molecule is a dimer composed of a brain-type subunit (B) and a muscle-type subunit (M). There are usually three isozymes in normal human tissues, which are CK-BB (CK1), CK-MB (CK2) and CK-MM (CK3) in the order of electrophoresis. CK-BB is mainly found in smooth muscle and brain tissue, and almost none in serum; CK-MB mainly exists in myocardial tissue, accounting for 0~4% of CK in serum; CK-MM is mainly present in skeletal muscle, accounting for 96%~100% of CK in serum. CK-MB has its own subtypes, including MB2 (tissue form) and MB1 (transformed form). After the release of CK-MB2 from the myocardium, the carboxy-terminus is hydrolyzed by plasma carboxypeptidase N, and a lysine residue is removed to be converted to the serum-modified isoform CK-MB1. CK and CK-MB are one of the sensitive indicators of myocardial tissue injury, especially CK-MB is more specific. The increase in CK during myocardial injury is mainly due to the increase in CK-MB, which is manifested by the simultaneous increase of both.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee